Hemerion
Pre-clinicalAdvancing cancer therapies with Hemerion Therapeutics' innovative technology to fight brain cancer and glioblastoma.
Founded
2016
Focus
Small Molecules
About
Advancing cancer therapies with Hemerion Therapeutics' innovative technology to fight brain cancer and glioblastoma.
Funding History
1Total raised: $4M
Seed$4MUndisclosedSep 15, 2021
Company Info
TypePrivate
Founded2016
LocationParis, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile